Cite
HARVARD Citation
Bhandari, S. et al. (2021). Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial. Nephrology dialysis transplantation. 36 (1), pp. 111-120. [Online].